Heck D E, Bisaccia E, Armus S, Laskin J D
Department of Environmental and Community Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway 08854.
Cancer Chemother Pharmacol. 1991;28(5):344-50. doi: 10.1007/BF00685687.
Treatment of peripheral blood mononuclear cells with 8-methoxypsoralen (8-MOP) and ultraviolet light, a procedure known as PUVA, has been found to be useful in the management of systemically disseminated cutaneous T-cell lymphoma (CTCL). In the present study we used a highly sensitive flow cytometric assay in conjunction with the hydroperoxide-sensitive dye 2',7'-dichlorofluorescein diacetate to measure intracellular hydrogen peroxide in normal lymphocytes and CTCL following PUVA treatment. Based on their laser light-scattering properties, lymphocytes were separated into three major subpopulations. We found that ultraviolet light alone caused an increase in the hydrogen peroxide content of each of the subpopulations, a response that was augmented when the cells were pretreated with 8-MOP (50 ng/ml). Cells from CTCL patients were more sensitive to the effects of 8-MOP than were normal lymphocytes. In both cell types, the production of hydrogen peroxide was found to be inhibitable by catalase. We noted an increase in hydrogen peroxide production following photopheresis; however, this was observed only 24 h after treatment. In addition, a further increase in hydrogen peroxide production was observed in lymphocytes isolated from peripheral blood that had been obtained from patients at 15 min after a second photopheresis treatment. Hydrogen peroxide is known to modulate the action of cytokines as well as the immunological responses of leukocytes. Our data suggest that the production of hydrogen peroxide by lymphocytes may be important in the action of PUVA in CTCL.
用8-甲氧基补骨脂素(8-MOP)和紫外线处理外周血单核细胞,即所谓的补骨脂素紫外线A光化学疗法(PUVA),已被发现对系统性播散性皮肤T细胞淋巴瘤(CTCL)的治疗有用。在本研究中,我们使用一种高度灵敏的流式细胞术检测方法,并结合对过氧化氢敏感的染料二氯荧光素二乙酸酯,来测量正常淋巴细胞和经PUVA治疗后的CTCL细胞内的过氧化氢含量。根据淋巴细胞的激光散射特性,将其分为三个主要亚群。我们发现,仅紫外线就能使每个亚群的过氧化氢含量增加,当细胞用8-MOP(50纳克/毫升)预处理时,这种反应会增强。CTCL患者的细胞比正常淋巴细胞对8-MOP的作用更敏感。在这两种细胞类型中,过氧化氢的产生都可被过氧化氢酶抑制。我们注意到光分离置换术后过氧化氢产生增加;然而,这仅在治疗后24小时观察到。此外,在第二次光分离置换治疗后15分钟从患者外周血中分离出的淋巴细胞中,观察到过氧化氢产生进一步增加。已知过氧化氢可调节细胞因子的作用以及白细胞的免疫反应。我们的数据表明,淋巴细胞产生过氧化氢可能在PUVA治疗CTCL的作用中起重要作用。